Page last updated: 2024-10-29

iodixanol and Azotaemia

iodixanol has been researched along with Azotaemia in 2 studies

iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.

Research Excerpts

ExcerptRelevanceReference
"In diagnosing acute pulmonary embolism (PE) in azotemic patients, scintigraphy and magnetic resonance imaging are frequently inconclusive or not available in many hospitals."1.35Minimizing contrast medium doses to diagnose pulmonary embolism with 80-kVp multidetector computed tomography in azotemic patients. ( Björk, J; Hansson, K; Holmquist, F; Nyman, U; Pasquariello, F, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holmquist, F1
Hansson, K1
Pasquariello, F1
Björk, J1
Nyman, U2
Elmståhl, B1
Leander, P1

Other Studies

2 other studies available for iodixanol and Azotaemia

ArticleYear
Minimizing contrast medium doses to diagnose pulmonary embolism with 80-kVp multidetector computed tomography in azotemic patients.
    Acta radiologica (Stockholm, Sweden : 1987), 2009, Volume: 50, Issue:2

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Azotemia; Contrast Media; Female; Humans; Linear Mode

2009
Suggesting gadolinium-based contrast media for CT in azotemic patients is not based on historical, clinical, and experimental data.
    Radiology, 2007, Volume: 244, Issue:2

    Topics: Animals; Azotemia; Contrast Media; Gadolinium DTPA; Humans; Kidney Diseases; Mice; Tomography, X-Ray

2007